Premier Anti-Aging Co., Ltd.
TSE:4934.T
719 (JPY) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) JPY.
2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | |
---|---|---|---|---|---|---|---|
Revenue
| 20,359 | 26,400.665 | 33,911.903 | 32,812.74 | 20,507.496 | 11,925.862 | 4,974.462 |
Cost of Revenue
| 4,258 | 7,157.776 | 7,282.948 | 6,382.853 | 4,024.462 | 2,215.385 | 924.821 |
Gross Profit
| 16,101 | 19,242.889 | 26,628.955 | 26,429.887 | 16,483.034 | 9,710.477 | 4,049.641 |
Gross Profit Ratio
| 0.791 | 0.729 | 0.785 | 0.805 | 0.804 | 0.814 | 0.814 |
Reseach & Development Expenses
| 495 | 589.425 | 432.218 | 211.199 | 88.022 | 39.184 | 10.881 |
General & Administrative Expenses
| 0 | 10,687.146 | 10,862.418 | 8,678.911 | 0 | 0 | 0 |
Selling & Marketing Expenses
| 0 | 8,598 | 12,920 | 12,812 | 0 | 0 | 0 |
SG&A
| 15,961 | 19,285.146 | 23,782.418 | 21,490.911 | 14,700.496 | 9,399.439 | 3,890.552 |
Other Expenses
| 15,961 | 22.454 | -0.311 | -32.424 | -2.121 | 0.399 | 8.093 |
Operating Expenses
| 15,961 | 19,854.571 | 24,214.636 | 21,749.81 | 14,829.184 | 9,467.927 | 3,911.52 |
Operating Income
| 139 | -611.681 | 2,414.318 | 4,680.076 | 1,653.849 | 242.55 | 138.12 |
Operating Income Ratio
| 0.007 | -0.023 | 0.071 | 0.143 | 0.081 | 0.02 | 0.028 |
Total Other Income Expenses Net
| -1,041 | -47.804 | 158.008 | -27.012 | -17.655 | -7.451 | 9.663 |
Income Before Tax
| -902 | -659.485 | 2,572.326 | 4,653.064 | 1,636.194 | 235.099 | 147.783 |
Income Before Tax Ratio
| -0.044 | -0.025 | 0.076 | 0.142 | 0.08 | 0.02 | 0.03 |
Income Tax Expense
| 581 | 74.488 | 1,147.904 | 1,859.436 | 492.739 | 60.759 | 52.302 |
Net Income
| -1,483 | -733.974 | 1,424.422 | 2,793.627 | 1,143.455 | 174.339 | 95.48 |
Net Income Ratio
| -0.073 | -0.028 | 0.042 | 0.085 | 0.056 | 0.015 | 0.019 |
EPS
| -170.06 | -84.17 | 163.35 | 320.37 | 131.43 | 20.04 | 10.97 |
EPS Diluted
| -170.06 | -84.17 | 163.11 | 320.37 | 131.43 | 20.04 | 10.97 |
EBITDA
| -630 | -383.989 | 2,636.965 | 4,691.966 | 1,683.676 | 272.647 | 157.325 |
EBITDA Ratio
| -0.031 | -0.015 | 0.078 | 0.143 | 0.082 | 0.023 | 0.032 |